Basics Aytu BioScience, Inc. Aytu BioScience Inc is engaged in acquiring, developing and commercializing products in the field of urology. It focuses on hypogonadism, prostate cancer, urinary tract infections and male infertility. IPO Date: May 23, 2017 Sector: Healthcare Industry: Pharma Market Cap: $18.13M Activated in VL: True Average Daily Range Avg Daily Range: $0.08 | 3.93% Avg Daily Range (30 D): $0.08 | 4.51% Avg Daily Range (90 D): $0.05 | 3.47% Institutional Daily Volume Avg Daily Volume: 1.58M Avg Daily Volume (30 D): 2.16M Avg Daily Volume (90 D): .76M Trade Size Avg Trade Size (Sh.): 479 Avg Trade Size (Sh.) (30 D): 222 Avg Trade Size (Sh.) (90 D): 223 Institutional Trades Total Inst.Trades: 67 Avg Inst. Trade: $1.58M Avg Inst. Trade (30 D): $.76M Avg Inst. Trade (90 D): $.76M Avg Inst. Trade Volume: .01M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.59M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 20.99K     News Jul 17, 2024 @ 11:03 AM Presenting on the Emerging Growth Conference 73 Da... Source: N/A Nov 15, 2023 @ 7:04 PM Why Shapeways Holdings Shares Are Trading Lower By... Source: Lisa Levin Sep 28, 2023 @ 5:04 PM Why CarMax Shares Are Trading Lower By Around 10%?... Source: Lisa Levin Sep 28, 2023 @ 3:55 PM Best Penny Stocks? 4 Hot Stocks With News This Wee... Source: J. Samuel Aug 9, 2023 @ 3:00 PM Benzinga's Top Ratings Upgrades, Downgrades For Au... Source: Benzinga Insights Financials   TTM Q3 2025 Q2 2025 Basic EPS $.2 $.65 $.13 Diluted EPS $.21 $-.26 Revenue $ 81.66M $ 18.45M $ 16.22M Gross Profit $ 52.16M $ 12.81M $ 10.79M Net Income / Loss $ 1.64M $ 3.99M $ .79M Operating Income / Loss $ -6.14M $ 2.42M $ -1.7M Cost of Revenue $ 29.5M $ 5.65M $ 5.44M Net Cash Flow $ -1.59M $ -2.23M $ PE Ratio     Splits Jan 06, 2023:   1:20 Dec 09, 2020:   1:10 Aug 13, 2018:   1:20 Aug 29, 2017:   1:20 Jul 01, 2016:   1:12 Jun 10, 2015:   11:134